Search Results - "Larcher, Fernando"
-
1
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
Published in Molecular therapy (01-11-2017)“…Designer nucleases allow specific and precise genomic modifications and represent versatile molecular tools for the correction of disease-associated mutations…”
Get full text
Journal Article -
2
Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study
Published in The Lancet (British edition) (21-11-2009)“…Summary Background Cell therapy for large burns is dependent upon autologous epidermis reconstructed in vitro. However, the effectiveness of current procedures…”
Get full text
Journal Article -
3
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37
Published in Journal of investigative dermatology (01-01-2008)“…The human antimicrobial peptide LL-37 plays an important role in host defense against infection. In addition to its antimicrobial action, other activities have…”
Get full text
Journal Article -
4
Induction of Scleroderma Fibrosis in Skin‐Humanized Mice by Administration of Anti−Platelet‐Derived Growth Factor Receptor Agonistic Autoantibodies
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2016)“…Objective To describe a skin–SCID mouse chimeric model of systemic sclerosis (SSc; scleroderma) fibrosis based on engraftment of ex vivo–bioengineered skin…”
Get full text
Journal Article -
5
Topical Enzyme-Replacement Therapy Restores Transglutaminase 1 Activity and Corrects Architecture of Transglutaminase-1-Deficient Skin Grafts
Published in American journal of human genetics (03-10-2013)“…Transglutaminase-1 (TG1)-deficient autosomal-recessive congenital ichthyosis (ARCI) is a rare and severe genetic skin disease caused by mutations in TGM1. It…”
Get full text
Journal Article -
6
A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa
Published in Experimental dermatology (01-10-2016)Get full text
Journal Article -
7
Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models
Published in Journal of investigative dermatology (01-01-2016)“…Psoriasis and atopic dermatitis are chronic and relapsing inflammatory diseases of the skin affecting a large number of patients worldwide. Psoriasis is…”
Get full text
Journal Article -
8
Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes
Published in Journal of investigative dermatology (01-04-2017)“…Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects in type-VII collagen (C7), a protein encoded by the COL7A1 gene and essential for…”
Get full text
Journal Article -
9
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
Published in Scientific reports (16-08-2024)“…Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease caused by loss of function mutations in the gene coding for collagen VII (C7) due…”
Get full text
Journal Article -
10
Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells
Published in Molecular therapy. Nucleic acids (01-06-2018)“…Recessive dystrophic epidermolysis bullosa is a severe skin fragility disease caused by loss of functional type VII collagen at the dermal-epidermal junction…”
Get full text
Journal Article -
11
Humanization of Tumor Stroma by Tissue Engineering as a Tool to Improve Squamous Cell Carcinoma Xenograft
Published in International journal of molecular sciences (12-03-2020)“…The role of stroma is fundamental in the development and behavior of epithelial tumors. In this regard, limited growth of squamous cell carcinomas (SCC) or…”
Get full text
Journal Article -
12
Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
Published in Molecular therapy. Methods & clinical development (08-12-2022)“…Recessive dystrophic epidermolysis bullosa, a devastating skin fragility disease characterized by recurrent skin blistering, scarring, and a high risk of…”
Get full text
Journal Article -
13
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination
Published in Molecular therapy (01-09-2013)“…Preclinical and clinical studies showed that autologous transplantation of epidermis derived from genetically modified epithelial stem cells (EpSCs) leads to…”
Get full text
Journal Article -
14
Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
Published in Molecular therapy. Nucleic acids (05-04-2016)“…Clonal gene therapy protocols based on the precise manipulation of epidermal stem cells require highly efficient gene-editing molecular tools. We have combined…”
Get full text
Journal Article -
15
Early, Non-Invasive Sensing of Sustained Hyperglycemia in Mice Using Millimeter-Wave Spectroscopy
Published in Sensors (Basel, Switzerland) (30-07-2019)“…Diabetes is a very complex condition affecting millions of people around the world. Its occurrence, always accompanied by sustained hyperglycemia, leads to…”
Get full text
Journal Article -
16
Classification of skin phenotypes caused by diabetes mellitus using complex scattering parameters in the millimeter-wave frequency range
Published in Scientific reports (19-07-2017)“…The pathological skin phenotype caused by hyperglycemia is an important indicator for the progress of diabetes mellitus. An early detection of diabetes assures…”
Get full text
Journal Article -
17
Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome
Published in Molecular therapy. Methods & clinical development (11-09-2020)“…Current efforts to find specific genodermatoses treatments and define precise pathogenesis mechanisms require appropriate surrogate models with human cells…”
Get full text
Journal Article -
18
Long-Term Survival of Type XVII Collagen Revertant Cells in an Animal Model of Revertant Cell Therapy
Published in Journal of investigative dermatology (01-02-2014)Get full text
Journal Article -
19
A humanized mouse model of HPV-associated pathology driven by E7 expression
Published in PloS one (23-07-2012)“…Human papillomavirus (HPV) is the causative agent of human cervical cancer and has been associated with oropharyngeal squamous cell carcinoma development…”
Get full text
Journal Article -
20
Long-term Engraftment of Single Genetically Modified Human Epidermal Holoclones Enables Safety Pre-assessment of Cutaneous Gene Therapy
Published in Molecular therapy (01-09-2007)“…Predicting the risks of permanent gene therapy approaches involving the use of integrative gene-targeting vectors has become a critical issue after the…”
Get full text
Journal Article